BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16329996)

  • 21. Streptococcal pyrogenic exotoxin B induces apoptosis and reduces phagocytic activity in U937 cells.
    Kuo CF; Wu JJ; Tsai PJ; Kao FJ; Lei HY; Lin MT; Lin YS
    Infect Immun; 1999 Jan; 67(1):126-30. PubMed ID: 9864206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The fate of SPE B after internalization and its implication in SPEB-induced apoptosis.
    Chang CW; Tsai WH; Chuang WJ; Lin YS; Wu JJ; Liu CC; Tsai PJ; Lin MT
    J Biomed Sci; 2007 May; 14(3):419-27. PubMed ID: 17380430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of different methods of stomach resection on the process of immunogenesis].
    Pilinenko IuS
    Khirurgiia (Mosk); 1972 Sep; 48(9):45-8. PubMed ID: 4661798
    [No Abstract]   [Full Text] [Related]  

  • 24. Functional relationship of factor B in the properdin system to C3 proactivator of human serum.
    Goodkofsky I; Lepow IH
    J Immunol; 1971 Oct; 107(4):1200-4. PubMed ID: 5093780
    [No Abstract]   [Full Text] [Related]  

  • 25. BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood.
    Santi I; Scarselli M; Mariani M; Pezzicoli A; Masignani V; Taddei A; Grandi G; Telford JL; Soriani M
    Mol Microbiol; 2007 Feb; 63(3):754-67. PubMed ID: 17212592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sickle-cell disease and the properdin system.
    Rosen FS
    N Engl J Med; 1973 Apr; 288(16):845-6. PubMed ID: 4144345
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi.
    Cestari Idos S; Krarup A; Sim RB; Inal JM; Ramirez MI
    Mol Immunol; 2009 Dec; 47(2-3):426-37. PubMed ID: 19783051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum levels of properdin, complement and thiocyanate during sodium thiocyanate administration].
    Weuffen W; Reissmann G; Kramer A; Schroeder H; Prott V; Prott P
    Z Gesamte Hyg; 1980; 26(10):724-5. PubMed ID: 7467493
    [No Abstract]   [Full Text] [Related]  

  • 29. Purification of streptococcal pyrogenic exotoxin a.
    Roggiani M; Schlievert PM
    Methods Mol Med; 2000; 36():59-66. PubMed ID: 21340964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of alternative pathway (AP) lytic activity and AP-dependent neutrophil phagocytosis with factor B levels and consumption in serum.
    Assis-Pandochi AI; Lucisano-Valim YM; Azzolini AE; Duarte CG; Russo EM; Carvalho IF
    Immunol Invest; 1999; 28(5-6):311-21. PubMed ID: 10574629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Domains of group A streptococcal M protein that confer resistance to phagocytosis, opsonization and protection: implications for vaccine development.
    McArthur JD; Walker MJ
    Mol Microbiol; 2006 Jan; 59(1):1-4. PubMed ID: 16359313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mannose-binding lectin (MBL) substitution: recovery of opsonic function in vivo lags behind MBL serum levels.
    Brouwer N; Frakking FN; van de Wetering MD; van Houdt M; Hart M; Budde IK; Strengers PF; Laursen I; Houen G; Roos D; Jensenius JC; Caron HN; Dolman KM; Kuijpers TW
    J Immunol; 2009 Sep; 183(5):3496-504. PubMed ID: 19657091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesterol-rich domains are involved in Bordetella pertussis phagocytosis and intracellular survival in neutrophils.
    Lamberti Y; Perez Vidakovics ML; van der Pol LW; Rodríguez ME
    Microb Pathog; 2008 Jun; 44(6):501-11. PubMed ID: 18276103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro.
    Leidi M; Gotti E; Bologna L; Miranda E; Rimoldi M; Sica A; Roncalli M; Palumbo GA; Introna M; Golay J
    J Immunol; 2009 Apr; 182(7):4415-22. PubMed ID: 19299742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the chemical composition of streptococcal co-opsonin.
    Rytel MW; Lytle RI; Sanders GA
    Experientia; 1964 Nov; 20(11):603-5. PubMed ID: 5857565
    [No Abstract]   [Full Text] [Related]  

  • 36. Properdin: New roles in pattern recognition and target clearance.
    Kemper C; Hourcade DE
    Mol Immunol; 2008 Oct; 45(16):4048-56. PubMed ID: 18692243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disorders of the complement and properdin systems.
    Alper CA; Rosen FS
    Ciba Found Symp; 1972; 9():283-96. PubMed ID: 4121647
    [No Abstract]   [Full Text] [Related]  

  • 38. Histidine and aspartic acid residues important for immunoglobulin G endopeptidase activity of the group A Streptococcus opsonophagocytosis-inhibiting Mac protein.
    Lei B; Liu M; Meyers EG; Manning HM; Nagiec MJ; Musser JM
    Infect Immun; 2003 May; 71(5):2881-4. PubMed ID: 12704162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the alternative (properdin) pathway of complement by Candida albicans and related species.
    Ray TL; Wuepper KD
    J Invest Dermatol; 1976 Dec; 67(6):700-3. PubMed ID: 794419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional characterization of BbCRASP-2, a distinct outer membrane protein of Borrelia burgdorferi that binds host complement regulators factor H and FHL-1.
    Hartmann K; Corvey C; Skerka C; Kirschfink M; Karas M; Brade V; Miller JC; Stevenson B; Wallich R; Zipfel PF; Kraiczy P
    Mol Microbiol; 2006 Sep; 61(5):1220-36. PubMed ID: 16925556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.